Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2019-01-08 2019-01-07
Drug Identification Number 02318709 02318709
Brand name MICARDIS PLUS MICARDIS PLUS
Common or Proper name MICARDIS MICARDIS
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients HYDROCHLOROTHIAZIDE TELMISARTAN HYDROCHLOROTHIAZIDE TELMISARTAN
Strength(s) 25MG 80MG 25MG 80MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28s 28s
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-02 2019-01-02
Estimated end date 2019-01-16 2019-01-16
Actual end date 2019-01-07 2019-01-07
Shortage status Resolved Actual shortage
Company comments Generics out of stock Generics out of stock
Health Canada comments